Thanks for getting in touch.<\/p>\n
Although short gaps for a few days are usually okay, a week off meds is enough for viral load to start to rebound. If you are unlucky, then\u00a0drug resistance can develop\u00a0while there are still\u00a0low levels of HIV drugs. If you only do this once, then the risk is low, but if it happened more frequently the risk will be higher.<\/p>\n
Two of the meds in your combination \u2013\u00a0tenofovir DF and emtricitabine (FTC) \u2013 would have continued to keep viral load load for a few days. The third drug \u2013 rilpivirine \u2013 has the higher risk of drug resistance, but the protection from the other two drugs might have helped.<\/p>\n
However, drug resistance is easier to develop to rilpivirine than many other drugs, so your doctor needs to know about the interruption. This is why it is so important to take rilpivirine\u00a0with food (so that drug levels are high enough).<\/p>\n
As this only happened once, there is a good chance that you will be lucky. Also, as this has already happened and you have restarted, it might be good to check viral load in\u00a02 to 4\u00a0weeks. If resistance did develop, this will find out quickly, rather than waiting for the normal 3 to 6 monthly text.<\/p>\n
Complera\u00a0is called Eviplera in the UK.<\/p>\n","protected":false},"excerpt":{"rendered":"
I missed 7 days of Complera, I just started back today. I switched insurance that was why it was a week unfortunately. How severe is my risk of drug resistance? <\/p>\n
I was undetectable for 3 years and CD4 has been over 800. <\/p>\n
I take great care of my body and health. Now I am nervous about the meds not working since I haven’t taken a pill for 7 days.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,7,35],"tags":[],"class_list":["post-12836","post","type-post","status-publish","format-standard","hentry","category-adherence","category-all-topics","category-resistance"],"_links":{"self":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/12836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/comments?post=12836"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/12836\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/media?parent=12836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/categories?post=12836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/tags?post=12836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}